{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:50:00Z","timestamp":1790196600652,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jacl.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T09:02:41Z","timestamp":1436605361000},"page":"692-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy and tolerability of coenzyme A vs pantethine for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study"],"prefix":"10.1016","volume":"9","author":[{"given":"Ya-qin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2015.07.003_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"363","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2015.07.003_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/14740338.2011.540237","article-title":"Safety review of combination drugs for hyperlipidemia","volume":"10","author":"Farnier","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jacl.2015.07.003_bib3","doi-asserted-by":"crossref","first-page":"21431","DOI":"10.1074\/jbc.M201708200","article-title":"Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics","volume":"277","author":"Daugherty","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2015.07.003_bib4","first-page":"1931","article-title":"Coenzyme A and dyslipidemia. Note III. Action of coenzyme A on changes in the blood lipid pattern after administration of dietary lipids","volume":"51","author":"Consolo","year":"1975","journal-title":"Boll Soc Ital Biol Sper"},{"key":"10.1016\/j.jacl.2015.07.003_bib5","first-page":"1920","article-title":"Coenzyme A and dyslipidemia. Note I. Rapid changes in lipid and lipoprotein levels induced with coenzyme A in humans","volume":"51","author":"Consolo","year":"1975","journal-title":"Boll Soc Ital Biol Sper"},{"key":"10.1016\/j.jacl.2015.07.003_bib6","first-page":"255","article-title":"The effects of an oral preparation of Coenzyme A on serum lipids of food-induced hyperlipidemia in rabbits and rats","volume":"25","author":"Na","year":"2004","journal-title":"Acad J Second Mil Med Univ"},{"key":"10.1016\/j.jacl.2015.07.003_bib7","first-page":"919","article-title":"Comparison of an oral preparation of Coenzyme A and pantethinein treatment of food-induced hyperlipidemia in rabbits","volume":"26","author":"Na","year":"2005","journal-title":"Acad J Second Mil Med Univ"},{"key":"10.1016\/j.jacl.2015.07.003_bib8","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1210\/jc.2012-2702","article-title":"The effects of coenzyme A on serum lipids in patients with hyperlipidemia: results of a multicenter clinical trial","volume":"98","author":"Chen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2015.07.003_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0021-9150(84)90009-1","article-title":"Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia","volume":"50","author":"Gaddi","year":"1984","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacl.2015.07.003_bib10","first-page":"234","article-title":"The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction","volume":"12","author":"Murai","year":"1985","journal-title":"Artery"},{"issue":"4","key":"10.1016\/j.jacl.2015.07.003_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nutres.2004.12.009","article-title":"Treatment of hyperlipoproteinemia with pantethine: a review and analysis of efficacy and tolerability","volume":"25","author":"McRae","year":"2005","journal-title":"Nutr Res"},{"issue":"8","key":"10.1016\/j.jacl.2015.07.003_bib12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.nutres.2011.08.001","volume":"31","author":"Rumberger","year":"2011","journal-title":"Nutr Res"},{"key":"10.1016\/j.jacl.2015.07.003_bib13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2015.07.003_bib14","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jacl.2015.07.003_bib15","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular out comes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jacl.2015.07.003_bib16","first-page":"833","article-title":"Effect of once high-dose coenzyme A on postprandial hypertriglyceridemia after a high-fat meal","volume":"19","author":"Liu","year":"2011","journal-title":"Chin J Arterioscler"},{"key":"10.1016\/j.jacl.2015.07.003_bib17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2015.07.003_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/heartjnl-2012-302689","article-title":"Mortality risk of triglyceride levels in patients with coronary artery disease","volume":"99","author":"Kasai","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jacl.2015.07.003_bib19","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.07.003_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1309\/22M22RF48PX9UT9T","article-title":"Comparison of apolipoprotein B and non-high density lipoprotein cholesterol for identifying coronary artery disease risk based on receiver operating curve analysis","volume":"127","author":"Levinson","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jacl.2015.07.003_bib21","first-page":"123","article-title":"High density- and beta-lipoprotein screening for risk of coronary artery disease in the context of new findings associated with reverse cholesterol transport","volume":"32","author":"Levinson","year":"2002","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"10.1016\/j.jacl.2015.07.003_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1-executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.07.003_bib23","first-page":"220","article-title":"Current medical aspects of pantethine","volume":"8","author":"Horvath","year":"2009","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.jacl.2015.07.003_bib24","first-page":"279","article-title":"Pantethine monograph","volume":"15","year":"2010","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.jacl.2015.07.003_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1872-034X.2007.00128.x","article-title":"Combined pantethine and probucol therapy patients with non-alcoholic teatohepatitis","volume":"37","year":"2007","journal-title":"Hepatol Res"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415003025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415003025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T04:47:38Z","timestamp":1566967658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287415003025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1933287415003025"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2015.07.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerability of coenzyme A vs pantethine for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}